Predicting Therapeutic Response and Degree of Pituitary Tumour Shrinkage during Treatment of Acromegaly with Octreotide LAR

Background/Aims: The efficacy of transsphenoidal surgery in the treatment of patients with acromegaly is largely dependent on tumour size. A reduction in pituitary tumour volume by medical therapy might therefore improve subsequent surgical cure rates. This study prospectively determined the effects...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hormone research 2004-01, Vol.62 (5), p.227-232
Hauptverfasser:	Jenkins, P.J., Emery, M., Howling, S.J., Evanson, J., Besser, G.M., Monson, J.P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acromegaly - drug therapy Acromegaly - pathology Adult Aged Antineoplastic Agents, Hormonal - administration & dosage Antineoplastic Agents, Hormonal - therapeutic use Delayed-Action Preparations Growth Hormone - blood Humans Insulin-Like Growth Factor I - metabolism Middle Aged Octreotide - administration & dosage Octreotide - therapeutic use Original Paper Pituitary Neoplasms - complications Pituitary Neoplasms - drug therapy Pituitary Neoplasms - etiology Pituitary Neoplasms - pathology Prospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!